MD - MEDNAX Inc Stock Price, Fair Value and News

9.23USD-0.17 (-1.81%)Market Closed

Market Summary

USD9.23-0.17

Market Closed

-1.81%

MD Stock Price

View Fullscreen

MD RSI Chart

MD Valuation

Market Cap

776.5M

Price/Earnings (Trailing)

-12.85

Price/Sales (Trailing)

0.39

EV/EBITDA

44.22

Price/Free Cashflow

5.65

MD Price/Sales (Trailing)

MD Profitability

EBT Margin

-2.42%

Return on Equity

-7.11%

Return on Assets

-2.72%

Free Cashflow Yield

17.69%

MD Fundamentals

MD Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

-3.39%

Rev. Growth (Qtr)

-2.01%

MD Earnings

Earnings (TTM)

-60.4M

Earnings Growth (Yr)

-519.05%

Earnings Growth (Qtr)

-681.02%

Breaking Down MD Revenue

Last 7 days

5.3%

Last 30 days

0.8%

Last 90 days

-2.6%

Trailing 12 Months

-34.8%

How does MD drawdown profile look like?

MD Financial Health

Current Ratio

1.24

Debt/Equity

0.73

Debt/Cashflow

0.22

MD Investor Care

Shares Dilution (1Y)

1.31%

Diluted EPS (TTM)

0.73

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	2.0B	2.0B	2.0B	2.0B
2022	1.9B	2.0B	2.0B	2.0B
2021	1.7B	1.8B	1.8B	1.9B
2020	1.8B	1.8B	1.8B	1.7B
2019	3.0B	2.6B	2.2B	1.8B
2018	3.5B	3.5B	3.5B	3.5B
2017	3.3B	3.3B	3.4B	3.5B
2016	2.9B	3.0B	3.1B	3.2B
2015	2.5B	2.6B	2.7B	2.8B
2014	2.2B	2.3B	2.4B	2.4B
2013	1.9B	2.0B	2.1B	2.2B
2012	1.6B	1.7B	1.8B	1.8B
2011	1.5B	1.5B	1.6B	1.6B
2010	1.3B	1.3B	1.4B	1.4B
2009	0	1.1B	1.2B	1.3B
2008	0	0	0	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of MEDNAX Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 13, 2024	pickert curtis	gifted	-	-	-12,923	evp, chief operating officer
Mar 01, 2024	wood lee	sold (taxes)	-45,402	9.15	-4,962	evp, natl & market operations
Mar 01, 2024	swift james d	sold (taxes)	-136,683	9.15	-14,938	chief executive officer
Mar 01, 2024	pickert curtis	sold (taxes)	-83,814	9.15	-9,160	evp, chief operating officer
Mar 01, 2024	moore mary ann e	sold (taxes)	-53,683	9.15	-5,867	evp, general counsel & sec
Mar 01, 2024	richards c marc	sold (taxes)	-196,066	9.15	-21,428	evp, chief financial officer
Dec 14, 2023	swift james d	sold	-55,219	9.58	-5,764	chief executive officer
Dec 14, 2023	moore mary ann e	sold	-9,331	9.62	-970	evp, general counsel & sec
Dec 14, 2023	moore mary ann e	sold	-11,063	9.62	-1,150	evp, general counsel & sec
Jun 14, 2023	swift james d	sold	-186,549	14.14	-13,193	chief executive officer

Which funds bought or sold MD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	AMALGAMATED BANK	reduced	-14.36	-23,000	269,000	-%
Apr 23, 2024	FIFTH THIRD BANCORP	added	35.92	3,691	11,615	-%
Apr 23, 2024	Louisiana State Employees Retirement System	reduced	-0.97	26,210	411,230	0.01%
Apr 23, 2024	Global Retirement Partners, LLC	unchanged	-	2.00	50.00	-%
Apr 23, 2024	WEDGE CAPITAL MANAGEMENT L L P/NC	sold off	-100	-762,488	-	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	-153,965	419,904	-%
Apr 22, 2024	Rosenberg Matthew Hamilton	sold off	-100	-28.00	-	-%
Apr 19, 2024	Maryland State Retirement & Pension System	unchanged	-	-11,200	272,245	-%
Apr 19, 2024	State of Alaska, Department of Revenue	reduced	-2.38	26,000	506,000	0.01%
Apr 18, 2024	SJS Investment Consulting Inc.	sold off	-100	-84.00	-	-%

Are Funds Buying or Selling MD?

Are funds buying MD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own MD

No. of Funds

Unveiling MEDNAX Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	alliancebernstein l.p.	9.4%	7,887,018	SC 13G/A
Feb 13, 2024	vanguard group inc	12.37%	10,393,239	SC 13G/A
Feb 12, 2024	earnest partners llc	5.7%	4,818,090	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	5.2%	4,409,901	SC 13G
Jan 22, 2024	blackrock inc.	16.2%	13,600,467	SC 13G/A
May 10, 2023	alliancebernstein l.p.	10.0%	8,392,304	SC 13G/A
Feb 14, 2023	alliancebernstein l.p.	7.8%	6,468,122	SC 13G/A
Feb 14, 2023	earnest partners llc	7.9%	6,546,580	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	11.72%	9,738,017	SC 13G/A

Recent SEC filings of MEDNAX Inc

View All Filings

Date Filed	Form Type	Document
Mar 28, 2024	DEFA14A	DEFA14A
Mar 28, 2024	DEF 14A	DEF 14A
Mar 28, 2024	ARS	ARS
Mar 14, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Feb 20, 2024	8-K	Current Report

Peers (Alternatives to MEDNAX Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	449.3B	371.6B	-0.74%	-0.51%	20.08	1.21	14.64%	11.24%
CI	103.0B	195.3B	0.26%	37.72%	19.17	0.53	8.17%	-20.79%
CVS	85.3B	357.8B	-12.72%	-6.73%	10.21	0.24	10.95%	93.52%
HCA	84.4B	65.0B	-3.19%	11.59%	16.11	1.3	7.86%	-7.11%
CNC	40.8B	154.0B	-1.43%	12.08%	15.09	0.26	6.54%	124.79%
DVA	11.6B	12.1B	-0.12%	51.97%	16.83	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.62%	17.22%	16.03	0.81	6.59%	6.24%
MID-CAP
CHE	9.3B	2.3B	-4.84%	8.83%	34.26	4.12	6.06%	9.17%
ACHC	6.5B	2.9B	-7.52%	-4.24%	-301.31	2.23	12.20%	-107.93%
AMN	2.2B	3.8B	-10.62%	-35.16%	10.28	0.57	-27.73%	-52.50%
AMEH	2.1B	1.4B	-5.65%	-0.29%	33.83	1.48	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.44%	-16.43%	24.79	1.46	11.31%	35.83%
BKD	1.3B	3.0B	7.61%	59.68%	-6.76	0.42	6.74%	20.73%
BEAT	53.7M	-	-3.27%	-3.72%	-3.67	-	-	-12.94%
AMS	18.7M	21.3M	13.26%	5.28%	35.15	0.88	8.00%	-62.25%

MEDNAX Inc News

Latest updates

MEDNAX Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-2.0%	496	507	501	491	514	490	486	482	499	493	473	447	417	461	415	441	459	455	439	427	888
Operating Expenses	30.4%	608	466	452	461	478	443	436	443	431	434	423	421	384	440	381	430	418	406	396	387	783
S&GA Expenses	-7.6%	53.00	57.00	58.00	59.00	51.00	58.00	61.00	61.00	59.00	67.00	71.00	67.00	55.00	66.00	60.00	67.00	59.00	63.00	63.00	59.00	106
EBITDA Margin	-84.7%	0.01*	0.10*	0.10*	0.10*	0.08*	0.10*	0.10*	0.10*	0.12*	0.11*	0.10*	-	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.8%	10.00	10.00	11.00	10.00	10.00	10.00	8.00	12.00	17.00	18.00	17.00	18.00	27.00	27.00	28.00	28.00	28.00	30.00	31.00	30.00	25.00
Income Taxes	-254.3%	-14.56	9.00	11.00	7.00	4.00	10.00	12.00	-7.40	13.00	12.00	7.00	-4.95	6.00	7.00	3.00	1.00	4.00	7.00	7.00	-1.51	22.00
Earnings Before Taxes	-550.3%	-138	31.00	39.00	21.00	28.00	39.00	43.00	-28.35	54.00	43.00	38.00	0.00	10.00	4.00	10.00	-17.41	14.00	20.00	13.00	11.00	83.00
EBT Margin	-141.2%	-0.02*	0.06*	0.06*	0.07*	0.04*	0.05*	0.06*	0.05*	0.07*	0.05*	0.03*	-	-	-	-	-	-	-	-	-	-
Net Income	-681.0%	-124	21.00	28.00	14.00	30.00	31.00	27.00	-21.19	48.00	31.00	35.00	18.00	-64.30	-41.04	-672	-18.71	9.00	-1,255	-8.24	-242	60.00
Net Income Margin	-165.1%	-0.03*	0.05*	0.05*	0.05*	0.03*	0.04*	0.04*	0.05*	0.07*	0.01*	-0.03*	-	-	-	-	-	-	-	-	-	-
Free Cashflow	-13.4%	69.00	80.00	89.00	-100	99.00	83.00	82.00	-97.48	44.00	61.00	54.00	-	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-4.6%	2,220	2,326	2,306	2,320	2,348	2,332	2,370	2,341	2,723	2,646	2,555	2,484	3,348	3,425	3,387	4,320	4,146	4,291	5,639	5,706	5,937
Current Assets	15.0%	483	421	398	409	428	424	459	440	841	788	752	665	1,549	1,651	688	941	732	965	986	1,057	660
Cash Equivalents	245.9%	73.00	21.00	6.00	6.00	10.00	9.00	14.00	7.00	387	358	338	270	1,124	295	132	312	108	25.00	36.00	46.00	41.00
Net PPE	0.7%	76.00	75.00	73.00	73.00	73.00	72.00	72.00	72.00	70.00	73.00	68.00	81.00	76.00	79.00	98.00	100	73.00	94.00	93.00	89.00	90.00
Goodwill	-9.7%	1,384	1,532	1,532	1,532	1,532	1,532	1,532	1,529	1,505	1,497	1,487	1,482	1,478	1,481	2,165	2,710	1,480	2,635	4,070	4,066	4,061
Liabilities	0.9%	1,371	1,358	1,363	1,410	1,456	1,473	1,524	1,464	1,826	1,800	1,746	1,717	2,600	2,620	2,561	2,832	2,647	2,811	2,914	2,926	2,850
Current Liabilities	11.0%	389	350	320	284	427	352	329	270	427	398	351	327	444	488	384	346	542	501	441	415	503
Long Term Debt	-0.5%	618	622	625	-	632	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	-12.3%	849	968	942	910	892	859	845	877	897	846	809	767	748	805	827	1,487	1,499	1,479	2,725	2,780	3,088
Retained Earnings	693.5%	149	-25.18	-46.57	-74.86	-89.06	-118	-149	-176	-155	-202	-233	-268	-286	-222	-179	491	510	501	1,757	1,801	2,094
Additional Paid-In Capital	0.4%	1,000	996	992	987	984	981	997	1,054	1,050	1,045	1,039	1,032	1,029	1,024	1,005	995	988	978	967	978	993
Shares Outstanding	0.1%	84.00	84.00	84.00	84.00	83.00	82.00	85.00	85.00	85.00	85.00	85.00	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-
Float	-	-	-	1,177	-	-	-	1,243	-	-	-	1,895	-	-	-	1,252	-	-	-	2,051	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-13.4%	69,250	79,938	89,054	-100,917	98,686	83,330	82,407	-97,482	44,236	61,102	53,587	-82,188	-11,866	169,935	188,435	-141,884	135,297	159,199	120,032	-56,817	151,377
Share Based Compensation	-4.4%	3,024	3,164	3,126	3,009	3,236	4,120	4,336	4,435	4,021	5,495	5,735	3,717	2,922	22,946	5,731	7,443	5,898	6,659	9,864	10,989	7,835
Cashflow From Investing	11.3%	-12,424	-14,004	-10,398	-11,350	-11,241	-6,088	-13,352	-26,273	-15,584	-41,214	14,089	-10,364	840,611	-3,441	-1,439	-20,220	156,977	-26,888	-18,943	-8,691	-94,989
Cashflow From Financing	90.6%	-4,747	-50,604	-78,931	108,567	-86,289	-82,662	-62,146	-256,457	825	-131	851	-761,661	586	-4,133	-366,650	366,039	-209,499	-143,150	-107,085	66,664	-30,321
Buy Backs	-100.0%	-	133	11.00	775	1,470	21,477	64,398	1,166	-	2,474	251	1,994	-2.00	5,452	501	2,542	356	415	65,527	78,982	-

MD Income Statement

2023-12-31

Condensed Consolidated Statements of Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net of Tax	$ 527	$ 1,694	$ 742

MD Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 73,258,000	$ 9,824,000
Short-term investments	104,485,000	93,239,000
Accounts receivable, net	272,313,000	296,787,000
Prepaid expenses	13,525,000	14,878,000
Income Taxes Receivable	7,565,000	0
Other current assets	12,308,000	13,261,000
Total current assets	483,454,000	427,989,000
Property and equipment, net	75,639,000	73,290,000
Goodwill	1,384,166,000	1,532,092,000
Intangible assets, net	21,240,000	18,491,000
Operating and finance lease right-of-use assets	70,294,000	66,924,000
Deferred income tax assets	102,852,000	105,925,000
Other assets	82,165,000	123,176,000
Total assets	2,219,810,000	2,347,887,000
Current liabilities:
Accounts payable and accrued expenses	350,798,000	374,225,000
Current portion of debt and finance lease liabilities, net	14,913,000	14,898,000
Current portion of operating lease liabilities	21,076,000	21,589,000
Income taxes payable	2,159,000	16,271,000
Total current liabilities	388,946,000	426,983,000
Line of credit	0	4,000,000
Long-term debt and finance lease liabilities, net	618,421,000	632,381,000
Long-term operating lease liabilities	47,238,000	44,213,000
Long-term professional liabilities	251,284,000	275,629,000
Deferred income tax liabilities	34,308,000	33,638,000
Other liabilities	30,552,000	39,411,000
Total liabilities	1,370,749,000	1,456,255,000
Commitments and contingencies
Shareholders' equity:
Preferred stock; $.01 par value; 1,000 shares authorized; none issued	0	0
Common stock; $.01 par value; 200,000 shares authorized; 00,000 and 82,947 shares issued and outstanding, respectively	840,000	829,000
Additional paid-in capital	999,906,000	983,601,000
Accumulated other comprehensive income (loss)	2,214,000	(3,735,000)
Retained deficit	149,471,000	(89,063,000)
Total shareholders' equity	849,061,000	891,632,000
Total liabilities and shareholders' equity	$ 2,219,810,000	$ 2,347,887,000

About MEDNAX Inc

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

CEO	Dr. James D. Swift M.D.
WEBSITE	pediatrix.com
INDUSTRY	Healthcare Plans
EMPLOYEES	5250

MEDNAX Inc Frequently Asked Questions

What is the ticker symbol for MEDNAX Inc? What does MD stand for in stocks?

MD is the stock ticker symbol of MEDNAX Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MEDNAX Inc (MD)?

As of Tue Apr 23 2024, market cap of MEDNAX Inc is 789.91 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MD stock?

You can check MD's fair value in chart for subscribers.

What is the fair value of MD stock?

You can check MD's fair value in chart for subscribers. The fair value of MEDNAX Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MEDNAX Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MEDNAX Inc a good stock to buy?

The fair value guage provides a quick view whether MD is over valued or under valued. Whether MEDNAX Inc is cheap or expensive depends on the assumptions which impact MEDNAX Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MD.

What is MEDNAX Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, MD's PE ratio (Price to Earnings) is -13.08 and Price to Sales (PS) ratio is 0.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MEDNAX Inc's stock?

In the past 10 years, MEDNAX Inc has provided -0.168 (multiply by 100 for percentage) rate of return.